House Committee To Hear From FDA’s Crawford On Flu Vaccine Shortage
This article was originally published in The Pink Sheet Daily
Executive Summary
CDC Director Gerberding and representatives from Sanofi-Aventis and MedImmune are also slated to appear before the House Government Reform Committee Oct. 8. The hearing is being called to evaluate government and industry responses to the vaccine shortage resulting from the U.K.’s suspension of Chiron’s license.